2024-10-27 02:18:55
Adlai Nortye Announces First Patient Dosed in Phase I Clinical Trial of the orally available, small-molecule PD-L1 inhibitor AN4005 for Advanced Tumors
Health/ 2023-07-22
Adlai Nortye Announces First Patient Dos...

NORTH BRUNSWICK,N.J. and HANGZHOU,China,Jan. 6,2022-- Adlai Nortye Ltd. ("Adlai Nortye"),a clinical-stage biopharmaceutical compan...

Nuance Pharma acquires Sino Health to further strengthen its commercial capabilities and expand pipelines
Health/ 2023-07-22
Nuance Pharma acquires Sino Health to fu...

SHANGHAI,Jan. 6,2022-- Nuance Pharma ("Nuance"or the "Company"),a specialty care focused biopharma with late late-stage ...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release